PHOENIX (Sept. 16, 2024) -- In recognition of Hispanic Heritage month, Somos Banner Health has launched a series addressing the unique healthcare needs of Hispanic individuals and families by discussing the most common diseases in the Hispanic community.
Studies have shown that Hispanics are 50% more likely to develop Alzheimer’s disease than Caucasians, making it crucial for Hispanic families to educate themselves about this mental disease.
One of the key recommendations to reduce the risk of Alzheimer's disease is to maintain a healthy lifestyle. This includes staying physically and mentally active, eating a balanced diet, reducing alcohol and tobacco use, ensuring quality sleep, and managing conditions such as high blood pressure and diabetes.
"It is imperative for Hispanic families to be proactive in understanding the risks and symptoms of Alzheimer’s disease and dementia. Seeking timely medical attention and consulting a specialist as soon as memory loss signs are noticed is crucial for obtaining a better treatment outcome and improving quality of life." - said Dr. Jeremy Pruzin, neurologist specializing in Dementia and other memory disorders at Banner Alzheimer’s Institute in Phoenix.
On Sept. 21, Banner Alzheimer's Institute played host to a bilingual class discussing about “Alzheimer’s in the Hispanic Community: Prevention, Care, and How You Can Help,” in Peoria.
The free event focused on brain health and Alzheimer’s disease prevention and treatment. Presentation topics included prevention, diagnosis, current treatments, caregiving for a loved one with Alzheimer’s and related dementias, and opportunities for participation in research. All educational presentations were in both Spanish and English. Visit BannerHealth.com/AlzheimersHispanicCommunity for more information.
Since its inception in 2006, Banner Alzheimer’s Institute has sought to find effective Alzheimer’s disease prevention therapies without losing another generation, establish a new model of dementia care for patients and family caregivers, and forge new models of collaboration in biomedical research. It has made groundbreaking contributions to the unusually early detection, tracking, diagnosis and study of Alzheimer’s, and aims to find an effective prevention therapy by 2025. It includes the pioneering Alzheimer’s Prevention Initiative, an extensive profile of research studies and clinical trials, comprehensive clinical, family and community service programs, a leading brain imaging research program, and strategic partnerships with public and private research organizations around the world. Learn more at http://www.bannerhealth.com/Alzheimers.
For further information contact us at: [email protected]